| Role |
Name |
Disclosure |
Details |
| Author | Cindy Li, DO, Dermatologist and Cosmetic Surgeon, Department of Dermatology, Kaiser Permanente Medical Group | Nothing to disclose | Details | | Coauthor | Richard K Scher, MD, Professor of Dermatology, University of North Carolina | Nothing to disclose | Details | | Medical Editor | Mark G Lebwohl, MD, Chairman, Department of Dermatology, Mount Sinai School of Medicine | Abbott Laboratories Actelion Amgen Astellas Basilea Briston-Myers Squibb Celtic Pharma Centocor Chattem DermiPsor DOV Galderma Genentech Genzyme Graceway Helix BioMedix Medicis Novartis OMP Pfizer PharmaDerm Stiefel Teva UCB Warner Chilcott Peplin Ranbaxy | Details | | Pharmacy Editor | David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Director, Division of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic | 3M Pharmaceutical Graceway Pharmaceuticals | Details | | Managing Editor | Jeffrey Meffert, MD, Assistant Clinical Professor of Dermatology, University of Texas Health Science Center-San Antonio | Nothing to disclose | Details | | CME Editor | Glen H Crawford, MD, Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital | Nothing to disclose | Details | | Chief Editor | William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System | elsevier american college of physicians | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Richard K Scher, Coauthor |
The contributor discloses no conflict of interest. |
|